Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis

American Journal of Ophthalmology

Volumn 139, Issue 6, 2005, Pages

  Bauer, Andrea M ^a   Fiehn, Christoph ^a,b   Becker, Matthias D ^a,c  

^a Department of Ophthalmology   (United States)

^b Center for Rheumatic Diseases   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; ENZYME INHIBITION; FEMALE; HUMAN; IRIDOCYCLITIS; LOW DRUG DOSE; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; TREATMENT OUTCOME;

EID: 20444460727     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.01.030     Document Type: Article

References (21)

1. P.G. Watson, S.S. Hayreh Scleritis and episcleritis Br J Ophthalmol 60 1976 163 191
2. C. Althaus, R. Sundmacher Skleritis und Episkleritis Ophthalmologe 93 1996 205 216
3. S.J. Tuft, P.G. Watson Progression of scleral disease Ophthalmology 98 1991 467 471
4. P.G. Watson, B.L. Hazelman The sclera in systemic disorders 1976 Saunders Philadelphia 90 91
5. C.S. Foster, S.L. Forstot, L.A. Wilson Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression Ophthalmology 91 1984 1253 1263
6. M. Sainz de la Maza, N.S. Jabbur, C.S. Foster An analysis of therapeutic decision for scleritis Ophthalmology 100 1993 1372 1376
7. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman TIS10, a phorbol ester tumor promotor-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandine synthase/cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
8. M.K. O'Banion, H.B. Sadowski, V. Winn, D.A. Young A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein J Biol Chem 266 1991 23261 23267
9. R.N. Dubois, S.B. Abramson, L. Crawford Cyclooxygenase in biology and disease FASEB J 12 1998 1063 1073
10. P.E. Lipsky, P. Brooks, L. Crawford Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and diseases Arch Intern Med 160 2000 913 920
11. L.P. Fong, M. Sainz de la Maza, B.A. Rice Immunopathology of scleritis Ophthalmology 98 1991 472 479
12. D.A. Jabs, R.A. Prendergast Autoimmune ocular disease in MRL/Mp-Ipr/Ipr mice is suppressed by anti-CD4 antibody Invest Ophth Vis Sci 32 1991 2718 2722
13. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature New Biol 231 1971 232 235
14. K.N. Hakin, P.G. Watson Systemic associations of scleritis Int Ophthalmol Clin 31 1991 111 129
15. M. McMullen, G. Kovarik, W.G. Hodge Use of topical steroid therapy in the management of non-necrotizing anterior scleritis Can J Ophthalmol 34 1999 217 221
16. D.A. Jabs, M. Abdulbaki, J.P. Dunn, M.J. Marsh Episcleritis and scleritis clinical features and treatment results Ophthalmology 130 2000 469 476
17. M.M. Wolfe, D.R. Lichtenstein, G. Singh Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 340 1999 1888 1899
18. D.A. Peura Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors Cleve Clin J Med 69 2000 31 39
19. C. Bombardier Comparison of upper gastrointestinal toxicity of refecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 343 2000 1520 1528
20. F.K.L. Chan Celecoxib versus diclofenac and omeprazol in reducing the risk of recurrent ulcer bleeding in patients with arthritis N Engl J Med 347 2002 2104 2110
21. P.S. Kelkar, J.H. Butterfield, H.G. Teaford Urticaria and angioedema from cyclooxygenase-2 inhibitors J Rheumatol 28 2001 2553 2554